Latest news with #MCAT


Hans India
2 days ago
- Health
- Hans India
MBBS Abroad: A practical guide for Indian students after NEET
As more than 23 lakh students vie for less than 1 lakh MBBS seats in India, a growing number of medical aspirants who appear for NEET are turning to international options to fulfill their dream of becoming doctors. Studying medicine abroad can open doors to global healthcare careers, but choosing the right college requires careful planning. Here's a practical guide to what Indian students should look for when evaluating MBBS programs abroad. Accreditation and Global Recognition The cornerstone of any reputable medical institution is its accreditation. This ensures that the curriculum meets globally recognized standards and that the degree will be accepted internationally. When evaluating medical schools, it's important to check for credentials such as approval by the Educational Commission for Foreign Medical Graduates (ECFMG) in the United States and a listing in the World Directory of Medical Schools, which is maintained through a partnership between the World Federation for Medical Education (WFME) and the Foundation for Advancement of International Medical Education and Research (FAIMER). ECFMG certification is particularly crucial for Indian students aspiring to pursue residency and practice in the United States. Similarly, recognition by the WHO (through its listing in the World Directory) often signifies that the degree is accepted in various countries worldwide. Without these recognitions, students may face significant hurdles in licensing and career progression. Therefore, verifying accreditations must be the first step in evaluating any foreign medical school. Clinical training Classroom learning must be complemented by strong clinical exposure. Look for institutions affiliated with reputed hospitals, particularly in the US or UK, as these settings provide access to advanced medical technology and a wide variety of clinical cases. Clinical rotations in these countries not only enhance skill development but also improve your chances of securing a residency. Ask about the structure and supervision of clinical rotations, duration, patient volume, and specialties covered. Quality clinical training abroad can make a significant difference in your transition from student to physician. Program Duration and Structure Medical program duration and structure differ globally. Prospective students must understand program length, preclinical/clinical phase breakdown, and teaching methods. Some countries offer shorter, intensive programs, while others have longer durations with varying specializations. Medical education in the US follows a graduate-entry model, requiring applicants to hold an undergraduate degree and take the MCAT exam, whereas several European countries offer six-year undergraduate medical programs. Caribbean institutions, conversely, often adopt a USMLE (United States Medical Licensing Examination) focused structure involving two years of basic sciences before clinical rotations. Admission Complexity, Exams, and Acceptance Rates Admission criteria differ greatly across countries. US medical schools are highly competitive, requiring MCAT scores, a strong undergraduate GPA, and extracurricular achievements. In contrast, institutions in Eastern Europe, Russia, or the Philippines often have simpler admissions processes but may offer limited exposure to international licensure pathways. Caribbean medical schools frequently allow direct entry after high school or offer a pre-med track, supported by academic counseling. When choosing a program, students must assess their own academic background and readiness for competitive exams to select the most suitable path. Cost and Financial Aid Studying abroad is a significant financial commitment. Consider the total cost, not just tuition, but also living expenses, travel, accommodation, exam fees, and eventual residency application costs. Numerous universities provide scholarships that are awarded based on either academic performance or financial need, making it essential for students to explore these options and review the criteria for eligibility. Students should also explore education loan options from Indian banks and NBFCs (Non-Banking Financial Company). Some foreign medical schools' partner with Indian lenders to simplify the loan process. Additionally, look for institutions offering flexible payment plans, which can ease the financial burden over time. A well-informed financial plan is critical to ensuring sustainability throughout your medical education. Career Pathways and Licensing Support Ultimately, the goal of pursuing medical education abroad is to become a licensed, practicing doctor. Therefore, it is essential to evaluate whether the medical school offers USMLE preparation support, has dedicated advisors and mentorship programs to assist with residency placements in the US or UK, and boasts a strong residency match rate. Additionally, it's important to look at where the alumni are currently practicing, whether in the US, UK, Canada, or India, as this reflects the institution's track record. Medical schools in the Caribbean that follow the USMLE pathway are particularly noteworthy in this context. Many of these institutions offer integrated Step 1 preparation, clinical training opportunities in US hospitals, and assistance with visas, making them structured and viable alternatives for Indian students aiming to build a medical career in North America. (The author is Country Head - India & South East Asia, Manipal's American University of Antigua (AUA) College of Medicine)


New York Post
3 days ago
- Politics
- New York Post
‘Iraq Syndrome' is dead, why PBS & NPR had to go and other commentary
Foreign desk: 'Iraq Syndrome' Is Dead 'Fear of the expression of American military power has now dissolved,' cheers Commentary's Seth Mandel. In his first term, President Trump 'adopted a modified Murphy's Law that also governed his predecessor's foreign policy: Anything that can be Iraq, will be Iraq.' But that looks to have changed 'when President Trump ordered the successful strikes on Iran's nuclear program.' Notably, 'Ukraine is now benefiting from the Iran strikes because reality has dispelled the fog of Iraq Syndrome and the president is seeing more clearly.' Fact is, 'the 'just like Iraq' line of thinking isn't accurate, and now Trump realizes that.' How 'fitting that Donald Trump, who rode the effects of Iraq Syndrome all the way to the presidency (twice), would be the one to cure American politics of this malady.' Health beat: Med-Schools' Merit Malpractice 'The Supreme Court banned racial preferences in university admissions, but finding ways to maintain them has become a cottage industry in higher education,' blasts The Wall Street Journal editorial board. Medical schools are one of the worst abusers. A new study finds 'admitted black applicants had lower MCAT scores than admitted white and Asian applicants at 22 out of 23 schools.' At places like the University of Wisconsin, 'a black medical school applicant was about 10 times more likely to be admitted than white or Asian applicants with identical test scores and GPA.' 'In the admissions cycles since 2023, little has changed.' 'Preferences that elevate less qualified doctors won't reduce inequities in public health, but they will stigmatize successful minority applicants who excel.' 'Oh, and to remind, racial preferences are against the law.' Media watch: Why PBS & NPR Had To Go 'Let us call a spade a spade: NPR and PBS have earned the 'woke' label,' roars TIPP Insights' editorial board. That's why it's so great Congress just cut off federal funds. 'NPR is a wolf in sheep's clothing. It enjoys the tax-exempt privileges of a 501(c)(3) organization, yet operates as a de facto mouthpiece for the Democratic Party and progressive ideology.' Two GOP senators, Susan Collins (Maine) and Lisa Murkowski (Alaska), voted against the cuts, crying about the 'impact on rural and tribal communities.' 'It's a flimsy argument': Both 'stream through the internet and airwaves,' so 'even the most rural communities can access their content instantly.' As we've asked before,'In a world of endless streaming and podcasting, why are taxpayers still funding a media cocoon for coastal elites?' Spy world: Russia-Hoax Document Bonanza The 'floodgates' of 'long-classified information' about the Russia-hoax scandal may finally be opening, reports Paul Sperry at RealClearInvestigations. Documents include a secret audit revealing that an 'intelligence community assessment on Russia ordered by President Obama after the 2016 election' was framed to portray Trump as beholden to Putin. A US intelligence official 'alleged the outgoing administration weaponized' Russian intelligence 'to sabotage President-elect Trump.' The information could 'strengthen a criminal case' against Obama intelligence officials like former CIA chief John Brennan. Former FBI officials say prosecutors have 'sufficient grounds to charge Obama's FBI and CIA officials with criminal conspiracy.' Statistician: Medicaid Fearmongers' Bad Math Yale law professor Natasha Sarin's claim that 'at least 100,000 more' Americans will die over 'the next decade' due to Medicaid cuts 'reflects a fundamental misunderstanding of the concept of 'statistical lives saved,'' warns Aaron Brown at Reason. Sarin 'and several other prominent journalists misinterpreted a recent working paper' by economists Angela Wyse and Bruce D. Meyer, which estimated 'that the Medicaid expansion reduced mortality among eligible adults between 0.40% and 4.52% ,' or about 27,400 lives. But these are 'statistical lives,' and 'these same government programs also take many statistical lives.' 'Counting statistical lives' is 'a debased currency, because it counts each actual life multiple times. And citing only the good side of the ledger makes it impossible to evaluate.' — Compiled by The Post Editorial Page


Express Tribune
5 days ago
- Business
- Express Tribune
BSEK puts off automated paper checking
The results of the 2025 annual matric examinations will be declared by July 31, said the chairman of the Board of Secondary Education Karachi (BSEK), Ghulam Hussain Soho, on Friday. However, he added that in case of any unforeseen technical or administrative delay, results will be announced in the first week of August. Speaking to The Express Tribune, the BSEK chief said that nearly 180,000 students appeared in this year's matric exams, making result preparation a logistical challenge. To address concerns of transparency and efficiency, he said that both manual checking and Optical Mark Recognition (OMR) systems will be used for assessment this year. Soho clarified that the previous software system, found to be both expensive and lacking transparency, has been scrapped after a review of its contract. A new, cost-effective system is being planned to streamline the process without compromising quality. The chairman further stated that OMR sheets will be used for compiling award lists this year, while from next year, all Class X exams and selected Class IX papers will be conducted using the OMR system to enhance transparency and expedite result processing. The goal is to complete result preparation within one month in the future. Chairman Soho also disclosed plans to revamp the existing mark-sheet, citing deficiencies in its design and quality. The BSEK will study mark-sheets from national and international educational boards to introduce a redesigned document that will feature improvements in weight, font size, colour scheme, security features, and overall design aesthetics, he added. The redesigned mark-sheet is expected to be introduced from next year to ensure both durability and protection against forgery. The chairman said that the BSEK is moving towards full digitisation of its services. An online portal is being developed, through which students will be able to easily access their personal data, forms, roll number slips, and examination results. He added that efforts are underway to automate all board operations. Chairman Soho revealed that the BSEK plans to make 70% of matric exam questions multiple-choice based in the coming years. This change aims to align students with the format of competitive entry tests such as ECAT and MCAT, enabling them to adjust to the testing pattern earlier and reducing reliance on expensive entry test preparation academies. This initiative, aimed at relieving financial pressure on parents and psychological stress on students, will be implemented after necessary approvals from the Inter Board Committee of Chairmen (IBCC). The BSEK has also decided to raise the passing marks to 40% from the upcoming academic year to improve academic standards and motivate students to work harder. Chairman Soho affirmed that all these reforms are part of the BSEK's broader strategy to modernise examination systems and enhance transparency in line with contemporary educational standards.

Wall Street Journal
16-07-2025
- Health
- Wall Street Journal
Dividing Doctors by Race
The Supreme Court banned racial preferences in university admissions, but finding ways to maintain them has become a cottage industry in higher education. Medical schools are among the frequent offenders, and a new report shows how schools have maintained different standards for applicants depending on their race. Do No Harm, a group that studies preferences in medicine, submitted a Freedom of Information Act request to 93 public medical schools for 2024 admissions data on race, undergraduate GPA, Medical College Admission Test (MCAT) scores, and whether or not the applicant was admitted. Twenty-three schools have responded so far, and the data suggests racial preferences are still going strong.
Yahoo
07-07-2025
- Business
- Yahoo
The stock market's biggest bet is setting investors up for a smackdown
Wall Street really needs AI to live up to the hype. A lot has been said about the emerging technology's world-changing potential: Its ability to create stunningly realistic images and videos, ace the LSAT and the MCAT, and complete rote research tasks. You could argue it's ready to augment — or even replace — entry-level jobs. These features have investors up and down the Street very excited. Staunch supporters like Fundstrat's Tom Lee and Wedbush's Dan Ives say AI could revolutionize the human experience. Research desks from big banks like Goldman Sachs and Bank of America have given subtler nods to the prospect of AI as a productivity and profit booster, which could provide an undercurrent to stock market success over the next several years. In fact, analysts are counting on the AI mania to fuel the market even as the White House's chaotic trade policy eats into corporate America's profit potential. Earnings for S&P 500 companies are projected to grow 8% this year, a fairly average showing for an anything-but-average year. What is notable is just how much of that growth relies on the tech sector: Silicon Valley companies are expected to boost their earnings by 21% — the highest growth of any sector. By contrast, profits for retailers are forecast to grow a measly 2.5%. Within the tech sector, semiconductor companies — one of the most globally exposed industries on the stock market — are expected to supercharge profit this year, with a projected climb of 49%. This enthusiasm is a signal Wall Street is betting that demand for AI's use cases will supersede tariff turmoil or job market wobbles. AI's growth has been incredible, and its adoption has been strong enough to leave its fingerprints on economic data sets like business investment and manufacturing spending. Yet no matter how rabid the world is about AI's possibilities, the amount that investors are relying on the tech to fuel the market's gains — especially in the face of rising economic uncertainty — feels short-sighted. Tech stocks helped the market recover from its April malaise, yet earnings expectations and economic momentum are even weaker than they were at the lowest point of the sell-off. This combination leaves the stock market in a precarious spot: Either AI needs to live up to the hype, or investors could be looking at a gnarly second half of the year. One way to tell the story of human history is through our technology — the lightbulb, the calculator, the tractor, the computer all stand as markers to our societal progress and have helped drive the level of efficiency and productivity we enjoy. Tech has perhaps played an equally prominent role in our investment portfolios. The Magnificent Seven stocks — Apple, Amazon, Alphabet, Meta, Microsoft, Tesla, and Nvidia — are collectively worth $18 trillion, or about 33% of the S&P 500's total market value. Together, their stock prices have increased 330% over the past five years, compared with a 100% rise in the S&P 500. It makes sense. Big Tech's products have become deeply integrated into our daily lives, and that level of ubiquity has also captured Wall Street's attention. Venture capital fundraising reached a record in the first quarter amid a huge appetite for AI investment, and S&P 500 companies mentioned AI more than tariffs on second-quarter conference calls. The $65 trillion US stock market may be particularly gripped by Big Tech's ups and downs these days, but it hasn't always been this way. Tech has averaged about 20% of the S&P 500's market value over the past decade, including 13% in the five years before COVID. The dominance is not set in stone, and while the wider market's fortunes are tied to tech now, that may not always be the case. While the stock market may seem like one big proxy for the tech sector's explosive growth right now, there is one deeper connection that should draw investors' attention. Over time, the S&P 500 has been attached at the hip to the fate of the broader US economy. Eight of the past 12 market crashes — S&P drops of 20% or more — overlapped with recessions. No matter how high-flying an industry is, recessions tend to pull stock prices and business hopes back to Earth. The internet revolutionized the world in the late 1990s, and the explosion in social media dominated the 2010s, but the information sector has shed employees and seen share prices fall in the past three recessions. Given that setup, we've set the stage for a portfolio smackdown of the ages. Economists are worried a recession is coming, yet investors are surprisingly upbeat about AI's prospects — so upbeat that they've bid S&P 500 tech stocks to nearly a record high. Sell-side analysts who evaluate company-level trends are similarly optimistic. But in the real economy, layoffs are growing, and hiring has ground to a halt. The sharply diverging views between economists and stock analysts mean someone has to be wrong. The freight train that is AI adoption — a three-year story of rapid innovation and progress — could collide with a massive wall from historic tariffs, high interest rates, and low consumer confidence. What's particularly rich about this is that tech companies are the most exposed sector to global tariffs. They gather the highest percentage of revenue internationally, plus they have the most suppliers and factories outside US borders. In fact, semiconductor companies — the firms providing chips for AI technology — are expected to hit that aforementioned 49% earnings growth despite generating 67% of their revenue abroad and sourcing 70% of their supplies from overseas. Some analysts believe that if AI hopes can keep the stock market chugging along, maybe it can do the same to the economy. After all, companies invested an inflation-adjusted $2.2 trillion on computers and other processing equipment last quarter, about one-seventh of the $16 trillion Americans spent on goods and services. Investing more in AI does ultimately help boost the economy, but that $2 trillion is peanuts compared with the real engine of the US economy. Americans' spending accounts for about 70% of GDP — by far the biggest driver of output — and spending has dropped in each of the past nine recessions. If tariffs intimidate consumers and lead to layoffs that decimate American incomes, then the economy is probably bound for a crisis — whether the robots pan out or not. And based on history, an economic crisis could topple the stock market. The math shows us that AI isn't much of a match for some effects of tariffs and may not logistically be enough to save the economy from ruin. Your portfolio's outcome may be a different story, though. This is when I have to introduce you to one of the most frustrating adages of investing: The stock market is not the economy. The economy is the value that we create — the hard assets, the cash spent, the paychecks we get. Stocks are an expression of that value, but they use the present reality to project future expectations. AI's impact on the economy may not bear out through numbers. But in your portfolio, AI's influence depends on how willing we are to collectively dream up better days ahead in terms of what AI is capable of and how much money AI-dominant firms will amass in the years to come. Dreaming is already a big part of the AI trade. S&P 500 tech companies' estimated earnings grew about 50% in 2023 and 2024, yet their share prices jumped 112%. Nothing is cut-and-dried when it comes to the stock market. It is the ultimate tangled web of logic, psychology, and mixed incentives. The stock market's future depends on investors' ability to dream, and people are willing to dream when they feel confident in the present moment. The problem is, investors are awfully confident about tech stocks right now. S&P 500 tech companies made up about 23% of total index profits in the first quarter, yet their shares account for 32% of the S&P 500's value. To close that gap, tech profits would have to grow 40%, or tech stocks would have to drop 29% from their end-of-June levels. Stocks can thrive when expectations are higher than reality, but in these conditions, they require reasons to stay hopeful. The problem arises when investors aren't willing to dream. When they're too focused on present issues to give compelling stories the benefit of the doubt. Or in big market drops, crushed by financial strain. Then, the numbers matter. People claw for any concrete evidence of AI's value. They demand proof of profits, even though companies are spending money on a pivot to the next big thing. Stock prices adjust, and if you hold a swath of US stocks or index funds, your money is probably heavily exposed to this reality check. This is what happened in 2000. Investors were willing to dream about this brave new technology called the World Wide Web until interest rates climbed too high and the reality of how much computing was needed for Y2K was found to be way overblown. Suddenly, the dream died, and tech stock prices came back down to reality. These days, we all know that dream wasn't completely off base. Yet share prices took an 80% crash before the promise of the new tech came to fruition. This is what I worry about the most in the clash between AI and the economy. We're somewhere between AI saving the world and being an overhyped bust of a technology that can be ripped off by another country. I'm not foolish enough to call this a bubble, and I think AI will eventually deliver benefits for our economy. We're not there yet, though, even though investors like to think so. It takes years for big technological trends to take hold, and productivity usually shines through when workers feel empowered and companies feel comfortable expanding. That's far from the case right now — business confidence is in the dumps, so we're in the opposite scenario. When the economy is getting weaker, it's best to grasp onto what's real in your portfolio. And there's a striking gap between AI and reality. Callie Cox is the chief market strategist at Ritholtz Wealth Management and the author of OptimistiCallie, a newsletter of Wall Street-quality research for everyday investors. You can view Ritholtz's disclosures here. Read the original article on Business Insider Sign in to access your portfolio